Evidence map›Paper›PMID 24886671›Full record

Trial reportHealth and quality of life outcomes2014

Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study.

Momar Diouf, Benoist Chibaudel, Thomas Filleron, Christophe Tournigand, Marine Hug de Larauze, Marie-Line Garcia-Larnicol, Sarah Dumont, Christophe Louvet, Nathalie Perez-Staub, Alexandra Hadengue and 2 more

Registry-linked trialAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in Health and quality of life outcomes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02844608 (Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon), which is not on this map. Cited by 18 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02844608 naunknown statusnot on this mapstarted 2016, after this paper: background citation

Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon

TypeinterventionalSponsorCentre Hospitalier Universitaire de BesanconRan2016 to 2019Enrolled152ConditionsBreast Cancer, Colorectal Cancer, Lung CancerArmsQuality of Life Questionnaires
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Patient-reported outcomes as predictors of survival in patients with bowel cancer: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Pooled it
  3. Pooled it
  4. A systematic review of the impact of pain on overall survival in patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Observational
  9. Observational
  10. The role of health-related quality of life in improving cancer outcomes.Journal of clinical and translational research · 2023
    Article
  11. Article
  12. Article
  13. Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
  14. Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS).Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2019
    Article
  15. Article
  16. Review
  17. Article
  18. Colorectal cancer.Nature reviews. Disease primers · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Momar DioufDirection de la Recherche Clinique et de l'Innovation, Centre Hospitalier Universitaire Amiens, Nord, 1, Place Victor Pauchet, F-80054, Amiens, Cedex, France. diouf.momar@chu-amiens.fr.
Benoist Chibaudel
Thomas Filleron
Christophe Tournigand
Marine Hug de Larauze
Marie-Line Garcia-Larnicol
Sarah Dumont
Christophe Louvet
Nathalie Perez-Staub
Alexandra Hadengue
Aimery de Gramont
Franck Bonnetain

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth-related quality of life (QoL) has prognostic value in many cancers. A recent study found that the performance of prognostic systems for metastatic colorectal cancer (mCRC) were improvable. We evaluated the independent prognostic value of QoL for overall survival (OS) and its ability to improve two prognostic systems'performance (Köhne and GERCOR models) for patients with mCRC.

methodsThe EQ-5D questionnaire was self-completed before randomization in the OPTIMOX1, a phase III trial comparing two strategies of FOLFOX chemotherapy which included 620 previously untreated mCRC patients recruited from January 2000 to June 2002 from 56 institutions in five countries. The improvement in models' performance (after addition of QoL) was studied with Harrell's C-index and the net reclassification improvement.

resultsOf the 620 patients, 249 (40%) completed QoL datasets. The Köhne model could be improved by LDH, mobility and pain/discomfort; the C-index rose from 0.54 to 0.67. The associated NRI for 12-month death was 0.23 [0.05; 0.46]. Mobility and pain/discomfort could be added to the GERCOR model: the C-index varied from 0.63 to 0.68. The NRI for 12 months death was 0.35 [0.12; 0.44].

conclusionsMobility and pain dimensions of EQ5D are independent prognostic factors and could be useful for staging and treatment assignment of mCRC patients. Presented at the 2011 ASCO Annual Meeting (#3632).

Indexed as

Quality of LifeActivities of Daily LivingAgedColorectal NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm MetastasisPainPrognosisProportional Hazards ModelsSurveys and QuestionnairesSurvival Analysis

Identifiers

PMID24886671
PMCPMC4029890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.